Emmaus Life Sciences, Inc. Derivative Instruments Not Designated as Hedging Instruments, Gain
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain · last filed 2013-01-15
- Emmaus Life Sciences, Inc. derivative instruments not designated as hedging instruments, gain for the quarter ending 2012-09-30 was $6.03M, a 190.91% increase year-over-year.
- Emmaus Life Sciences, Inc. derivative instruments not designated as hedging instruments, gain for the quarter ending 2011-09-30 was $2.07M.
- Emmaus Life Sciences, Inc. derivative instruments not designated as hedging instruments, gain for fiscal 2012 was $6.95M, a 1.81% increase from fiscal 2011.
- Emmaus Life Sciences, Inc. derivative instruments not designated as hedging instruments, gain for fiscal 2011 was $6.83M.
| Period end | Derivative Instruments Not Designated as Hedging Instruments, Gain 3 month | Derivative Instruments Not Designated as Hedging Instruments, Gain 9 month | Derivative Instruments Not Designated as Hedging Instruments, Gain 12 month |
|---|---|---|---|
| 2012-09-30 | $6.03M derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-01-15 | $6.95M 10-K · filed 2013-01-15 | |
| 2012-06-30 | $918.00K 10-Q/A · filed 2012-09-11 | ||
| 2011-09-30 | $2.07M derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-01-15 | $6.83M 10-K · filed 2013-01-15 | |
| 2011-06-30 | $4.75M 10-Q/A · filed 2012-09-11 |